Amalgamated Bank’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$4.81M Buy
87,469
+149
+0.2% +$8.19K 0.04% 412
2025
Q1
$6.17M Sell
87,320
-3,728
-4% -$264K 0.05% 295
2024
Q4
$5.99M Buy
91,048
+382
+0.4% +$25.1K 0.05% 320
2024
Q3
$6.37M Sell
90,666
-5,256
-5% -$369K 0.05% 308
2024
Q2
$7.9M Buy
95,922
+85,177
+793% +$7.01M 0.07% 233
2024
Q1
$938K Sell
10,745
-5,619
-34% -$491K 0.01% 1068
2023
Q4
$1.58M Sell
16,364
-4,303
-21% -$415K 0.01% 992
2023
Q3
$1.83M Buy
20,667
+2,439
+13% +$216K 0.02% 907
2023
Q2
$1.58M Sell
18,228
-302
-2% -$26.2K 0.01% 969
2023
Q1
$1.8M Buy
18,530
+91
+0.5% +$8.85K 0.02% 905
2022
Q4
$1.91M Buy
18,439
+123
+0.7% +$12.7K 0.02% 915
2022
Q3
$1.55M Sell
18,316
-1,197
-6% -$101K 0.02% 945
2022
Q2
$1.62M Buy
19,513
+1,497
+8% +$124K 0.02% 943
2022
Q1
$1.39M Sell
18,016
-1,097
-6% -$84.6K 0.01% 1075
2021
Q4
$1.69M Sell
19,113
-191
-1% -$16.9K 0.01% 1018
2021
Q3
$1.49M Sell
19,304
-1,751
-8% -$135K 0.01% 1063
2021
Q2
$1.76M Buy
21,055
+12,244
+139% +$1.02M 0.01% 1023
2021
Q1
$665K Sell
8,811
-476
-5% -$35.9K 0.02% 817
2020
Q4
$814K Sell
9,287
-136
-1% -$11.9K 0.03% 679
2020
Q3
$717K Sell
9,423
-153
-2% -$11.6K 0.03% 639
2020
Q2
$1.18M Sell
9,576
-17,977
-65% -$2.22M 0.05% 351
2020
Q1
$2.33M Sell
27,553
-964
-3% -$81.5K 0.06% 310
2019
Q4
$2.41M Buy
28,517
+1,338
+5% +$113K 0.04% 408
2019
Q3
$1.83M Buy
27,179
+5,868
+28% +$396K 0.04% 475
2019
Q2
$1.83M Sell
21,311
-2,837
-12% -$243K 0.04% 451
2019
Q1
$2.15M Buy
24,148
+712
+3% +$63.2K 0.05% 355
2018
Q4
$2M Sell
23,436
-754
-3% -$64.2K 0.06% 317
2018
Q3
$2.35M Sell
24,190
-569
-2% -$55.2K 0.06% 313
2018
Q2
$2.33M Buy
24,759
+1,954
+9% +$184K 0.06% 315
2018
Q1
$1.85M Buy
22,805
+2,509
+12% +$203K 0.05% 412
2017
Q4
$1.81M Buy
20,296
+2,052
+11% +$183K 0.05% 402
2017
Q3
$1.7M Buy
18,244
+402
+2% +$37.4K 0.05% 362
2017
Q2
$1.62M Buy
17,842
+7,628
+75% +$693K 0.05% 373
2017
Q1
$897K Sell
10,214
-5,445
-35% -$478K 0.04% 491
2016
Q4
$1.3M Buy
15,659
+3,399
+28% +$282K 0.06% 354
2016
Q3
$1.13M Buy
12,260
+456
+4% +$42.2K 0.07% 307
2016
Q2
$1.09M Buy
11,804
+6,500
+123% +$598K 0.06% 323
2016
Q1
$437K Buy
5,304
+1,521
+40% +$125K 0.04% 608
2015
Q4
$396K Sell
3,783
-1,226
-24% -$128K 0.05% 580
2015
Q3
$528K Buy
5,009
+125
+3% +$13.2K 0.06% 470
2015
Q2
$668K Buy
4,884
+375
+8% +$51.3K 0.07% 378
2015
Q1
$562K Buy
4,509
+866
+24% +$108K 0.07% 361
2014
Q4
$329K Buy
3,643
+141
+4% +$12.7K 0.05% 531
2014
Q3
$253K Buy
3,502
+276
+9% +$19.9K 0.04% 675
2014
Q2
$201K Sell
3,226
-64
-2% -$3.99K 0.03% 819
2014
Q1
$224K Sell
3,290
-71
-2% -$4.83K 0.04% 701
2013
Q4
$236K Buy
+3,361
New +$236K 0.04% 682